Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery.
about
Targeting of Synthetic Gene Delivery SystemsCharacterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNSLipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapySide-effects of a systemic injection of linear polyethylenimine-DNA complexesMonitoring DNA/poly-L-lysine polyplex formation with time-resolved multiangle laser light scattering.Very long-chain fatty tails for enhanced transfection.Drug transport to brain with targeted liposomesLipoplexes and tumours. A review.In vivo gene delivery by cationic tetraamino fullerene.Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipidBlock and graft copolymers and NanoGel copolymer networks for DNA delivery into cell.Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult miceThe effect of liposome size on the final lipid/DNA ratio of cationic lipoplexesDevelopment and characterization of pectinate micro/nanoparticles for gene deliveryCationic lipid-mediated transfection in vitro and in vivo (review).Tumor suppressor gene-based nanotherapy: from test tube to the clinic.Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes.Myths concerning the use of cationic liposomes in vivo.Delivery systems for pulmonary gene therapy.Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes.Non-viral delivery of ribozymes for cancer gene therapy.Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primatesLiposome-nucleic acid immunotherapeutics.DNA packing in stable lipid complexes designed for gene transfer imitates DNA compaction in bacteriophage.PEGylation as a strategy for improving nanoparticle-based drug and gene deliverySubcellular Behaviour Evaluation of Nanopharmaceuticals with Aggregation-Induced Emission Molecules.Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.Polymers for DNA delivery.Pharmacokinetic considerations regarding non-viral cancer gene therapy.Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle deliveryFunctional lipids and lipoplexes for improved gene delivery.Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA.Lipid-based nanotherapeutics for siRNA deliveryNonviral vectors for the delivery of small interfering RNAs to the CNS.
P2860
Q24791090-2414F605-EB2C-48F4-BACE-40AAD70E297CQ24797850-4D4A4339-D109-43EF-B295-82D141FC804EQ27025394-14A17C18-945D-4A55-B7B3-1F45A365808EQ27317260-417B6081-853F-41E2-B7D0-223F8DC6D359Q28005535-1E67692F-7ABF-460E-AAB4-143216AFDAC9Q28192320-68ECC5C0-BC57-4FB5-B78B-17DFA1C646D9Q30650088-FE3D5ACB-E8CB-42E3-946C-90EC4D3F1620Q33392896-91BC813E-48BD-40C4-8F62-E5D80E5DA392Q33569479-BAA4888F-B7E4-4194-AE87-4CB4C6E216ACQ33723073-DF563276-E6E7-4A0F-9950-08DF0D7FBBF5Q33777666-50CF43B1-3F6E-4696-9CFA-DAC884B7471BQ33941782-75B14CF9-3495-49F6-AD7B-E48EA65D513FQ33942174-AFD8594D-605D-4B13-83F2-CE5376FBAB41Q34020968-A888789F-5A71-4C48-954A-84C8EE038B44Q34184996-C7718563-C805-4D05-BA64-E17B9BC294FBQ34293392-44416DCB-94B1-4C06-BCA8-F469A8E74A32Q34313548-9963E40B-D17C-49C2-A81D-0ADBC38226DCQ34730883-52C880A4-03DE-48BC-B52A-A609071066E8Q35071617-7272AB98-A87E-4876-8F17-1397BD51EBEDQ35116145-02648BEB-8269-48A4-B084-8217BE9B97CBQ35627914-37FF53DF-B8BD-4473-8A77-7E69341FC1E9Q35914942-892EBF15-76DF-49F6-A54E-D70B56E69FACQ35925607-6EE44FF7-EF82-4748-BD02-B4D1EF211115Q36334067-D4876F0E-41A8-40DD-B72E-425310A655B1Q36438450-0019194A-256A-4432-B18A-5D1868BD0D24Q36517160-A9375994-33D6-4B3B-9F8D-B0A1EB82AC1DQ36535092-B20A9C36-EE8F-4A8A-B698-39739343777FQ36703361-079246B3-FEFC-4249-979F-3762FB122F98Q36752542-8ECECDED-8555-466F-A4F3-04B5E087B710Q36968187-FFD85D29-DB8C-466B-845E-B6B577BB34F4Q37002661-5E95FC92-A460-4463-87A6-AE005C8D4C2CQ37092309-49009790-BFFE-4200-BC78-93FAE6B545A0Q37149082-054A2AC8-65E7-4AD2-B519-9748902230AFQ37164976-62717006-521C-4EC5-80EF-80BD9DC0C61EQ37166374-463E3700-060C-4FB3-B8EA-6117DE7DBA66Q37167336-100D8BC1-C982-4318-A228-08AADAC3A742Q37283351-2409212D-055D-4A7B-8F4A-62FA4D52522AQ37403081-0151F311-3AE5-42A0-8E7F-0C4018AEADC8Q37670986-D546C131-78B0-4BBD-9419-8A341556DAD1Q37805489-E1A2C5C5-064C-4D40-BF61-811B58DCCB91
P2860
Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Factors influencing the effici ...... ted intravenous gene delivery.
@en
type
label
Factors influencing the effici ...... ted intravenous gene delivery.
@en
prefLabel
Factors influencing the effici ...... ted intravenous gene delivery.
@en
P2093
P2860
P356
P1433
P1476
Factors influencing the effici ...... ted intravenous gene delivery.
@en
P2093
Liggitt HD
Mounkes LC
P2860
P2888
P304
P356
10.1038/NBT0297-167
P577
1997-02-01T00:00:00Z
P6179
1042860966